Market Research Logo

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity

153 Pages GBI Research September 01, 2011 SKU: XGBR6511071

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity

Summary

GBI Research has released its latest research, “Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity” which provides insights into the licensing agreements of large pharmaceutical companies. The report provides an in-depth analysis of the major licensing agreement trends in the pharmaceutical industry along with product and technology licensing trends. In addition, the report also analyzes the top 20 pharmaceutical companies with respect to the licensing agreement activities.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes -
  • Major market trends that are expected to shape the licensing and deal making landscape in pharmaceutical industry
  • Trends in deals for product licensing and technology licensing agreements.
  • Extensive research and analysis of the licensing activity of large pharmaceutical companies.
  • Licensing and deal making segmentation of top 20 in the pharmaceutical companies by phase, type, geography and value
  • Company profiles of leading biotech companies active in licensing and deal making
Reasons to buy

The report will enhance your decision making capability. It will allow you to -
  • Develop market-entry and market expansion strategies by identifying the leading areas for licensing and deal making in the pharmaceutical industry.
  • Enable better product lifecycle management by identifying key phases of product licensing agreements.
  • Develop segment specific strategies for licensing and deal making in pharmaceutical industry.
  • Develop key strategic initiatives by understanding the key licensing and deal making focus areas of leading pharma companies.
  • Accelerate and strengthen your market position by identifying key companies for licensing agreements.

Show Full Description


Show Table of Contents



Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines...

GBI Research
September 01, 2011

Search inside this report



Pricing & Delivery

Online Download
$3,500
Global Site License
$10,500

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report